{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T06:49:46Z","timestamp":1776840586679,"version":"3.51.2"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020084","name":"Guangzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["2023A03J0770"],"award-info":[{"award-number":["2023A03J0770"]}],"id":[{"id":"10.13039\/501100020084","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>\n                    Hepatitis and cirrhosis constitute a substantial global health burden, with therapeutic options remaining largely confined to antiviral agents and liver transplantation. Traditional Chinese medicine has long employed Epimedium species (Berberidaceae) for hepatoprotective indications, with contemporary investigations identifying prenylated flavonoids\u2014principally icariin and its active metabolite icaritin\u2014as the principal bioactive constituents. This integrative review systematically examined 33 high-impact studies published up to March 2026, selected based on a comprehensive search of PubMed, Web of Science, Scopus, Embase, Cochrane Library, CNKI, Wanfang, and Google Scholar. Included investigations were critically evaluated for mechanistic sophistication, translational validity, methodological rigor, and pharmacokinetic relevance. Preclinical evidence, derived predominantly from toxin-induced (e.g., CCl\n                    <jats:sub>4<\/jats:sub>\n                    , TAA), metabolic, and acute injury models, demonstrates that icaritin exerts consistent anti-fibrotic activity through dual inhibition of HIF-1\u03b1 and TGF-\u03b2\/Smad signaling, selective induction of hepatic stellate cell apoptosis, and suppression of angiogenesis via VEGF\/VEGFR2 blockade. Immunomodulatory properties observed in preclinical tumor models and early-phase clinical trials in advanced HBV-related hepatocellular carcinoma, encompass reduction of myeloid-derived suppressor cells (-43%), regulatory T cells (-31%), and enhancement of CD8+ T-cell function (+2.8-fold) providing proof-of-concept for immune modulation in an HBV-endemic population. Clinical data in liver disease remain limited to small, non-randomized studies (primarily in HCC), with no phase III trials specifically targeting fibrosis or cirrhosis endpoints. Critical evidence gaps\u2014including the absence of validation in viral hepatitis models, undefined pharmacokinetics in cirrhosis, and lack of drug-drug interaction data with antivirals\u2014currently preclude routine clinical application in hepatitis and cirrhosis. Safety analyses reveal dose-dependent hepatotoxicity at concentrations exceeding 50 \u03bcM icaritin and substantial inter-individual variability in gut microbiota-mediated bioactivation. Epimedium flavonoids exhibit multi-target therapeutic potential that bridges traditional botanical medicine and modern pharmacology, though critical translational gaps persist. Future investigations must prioritize phase III fibrosis trials, pharmacokinetic optimization in cirrhotic populations, and comprehensive drug-drug interaction studies with direct-acting antivirals to establish evidence-based clinical protocols.\n                  <\/jats:p>","DOI":"10.3389\/fcimb.2026.1799319","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:51:10Z","timestamp":1776837070000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The therapeutic potential of epimedium and its bioactive flavonoids in hepatitis and cirrhosis: an integrative review"],"prefix":"10.3389","volume":"16","author":[{"given":"Jianyi","family":"Zhang","sequence":"first","affiliation":[{"name":"Gastroenterology Department, The Affiliated Traditional Chinese Medicine Hospital, Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weichi","family":"Jiang","sequence":"additional","affiliation":[{"name":"Oncology Department, Guangdong Provincial Second Hospital of Traditional Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huigang","family":"Feng","sequence":"additional","affiliation":[{"name":"Intervention Department, The Affiliated Panyu Central Hospital of Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Yan","sequence":"additional","affiliation":[{"name":"Institute of Orthopedic Surgery, Xijing Hospital, Fourth Military Medical University","place":["Xi\u2019an, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Huang","sequence":"additional","affiliation":[{"name":"Intervention Department, The Affiliated Panyu Central Hospital of Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiwei","family":"Liang","sequence":"additional","affiliation":[{"name":"Intervention Department, The Affiliated Panyu Central Hospital of Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningyi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, The Affiliated Traditional Chinese Medicine Hospital, Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoming","family":"Huang","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, The Affiliated Traditional Chinese Medicine Hospital, Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujin","family":"Wu","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, The Affiliated Traditional Chinese Medicine Hospital, Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunhua","family":"Fan","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, The Affiliated Traditional Chinese Medicine Hospital, Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yilin","family":"Yang","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, The Affiliated Traditional Chinese Medicine Hospital, Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Liao","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, The Affiliated Traditional Chinese Medicine Hospital, Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiliang","family":"Huang","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, The Affiliated Traditional Chinese Medicine Hospital, Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiawei","family":"Fan","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, The Affiliated Traditional Chinese Medicine Hospital, Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Zeng","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, The Affiliated Traditional Chinese Medicine Hospital, Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinming","family":"Li","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Laser Life Science, College of Biophotonics and Guangzhou Key Laboratory of Spectral Analysis and Functional Probes, College of Biophotonics, South China Normal University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanwei","family":"Chen","sequence":"additional","affiliation":[{"name":"Intervention Department, The Affiliated Panyu Central Hospital of Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"B7","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.pharep.2017.02.016","article-title":"Icariin protects against thioacetamide-induced liver fibrosis in rats: implication of anti-angiogenic and anti-autophagic properties","volume":"69","author":"Algandaby","year":"2017","journal-title":"Pharmacol. Reports: Pr."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113180","article-title":"Anti-inflammatory and immunoregulatory effects of icariin and icaritin","volume":"151","author":"Bi","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000013935","article-title":"Efficacy and safety of Yinchen Sini decoction in treating biliary atresia patients after Kasai portoenterostomy: a systematic review and meta-analysis protocol","volume":"98","author":"Chen","year":"2019","journal-title":"Med. (Baltimore)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12885-019-5471-1","article-title":"First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: preliminary results of safety, durable survival and immune biomarkers","volume":"19","author":"Fan","year":"2019","journal-title":"BMC Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2174\/0109298673362768250417052953","article-title":"Icaritin attenuates HSC activation by down-regulating the HIF-1\u03b1 and TGF-\u03b2\/Smad signaling pathways to ameliorate liver fibrosis","author":"Feng","year":"2025","journal-title":"Curr. Med. Chem."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.120415","article-title":"Fufang epimedium formula alleviates acute liver injury through dual modulation of PI3K\/AKT\/Bcl-2 anti-apoptotic signaling pathway and cGAS-STING-IRF3 anti-inflammatory signaling pathway","volume":"353","author":"Feng","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28020517","article-title":"Icariin alleviates nonalcoholic fatty liver disease in polycystic ovary syndrome by improving liver fatty acid oxidation and inhibiting lipid accumulation","volume":"28","author":"Hai","year":"2023","journal-title":"Molecules"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1002\/eji.201948225","article-title":"Icaritin promotes tumor T-cell infiltration and induces antitumor immunity in mice","volume":"49","author":"Hao","year":"2019","journal-title":"Eur. J. Immunol."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12081917","article-title":"Icaritin exerts anti-cancer effects through modulating pyroptosis and immune activities in hepatocellular carcinoma","volume":"12","author":"Jiao","year":"2024","journal-title":"Biomedicines"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.70136","article-title":"First-line treatment of Icaritin and Thalidomide in a patient with hepatocellular carcinoma with PR: a case report","volume":"8","author":"Jin","year":"2025","journal-title":"Cancer Rep. (Hoboken NJ)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22060986","article-title":"Potential of Icariin metabolites from Epimedium koreanum Nakai as antidiabetic therapeutic agents","volume":"22","author":"Kim","year":"2017","journal-title":"Molecules"},{"key":"B6","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.jep.2011.06.030","article-title":"Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats","volume":"137","author":"Li","year":"2011","journal-title":"J. Ethnopharmacol."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.70104","article-title":"Icaritin-loaded liposomes mediated by hyaluronic acid promoted the anti-proliferation and senescence in Huh7 cells","volume":"86","author":"Lu","year":"2025","journal-title":"Drug Dev. Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jpha.2022.12.001","article-title":"Multidisciplinary strategies to enhance therapeutic effects of flavonoids from Epimedii Folium: integration of herbal medicine, enzyme engineering, and nanotechnology","volume":"13","author":"Lu","year":"2023","journal-title":"J. Pharm. Anal."},{"key":"B1","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1053\/j.gastro.2014.07.018","article-title":"Cell death and cell death responses in liver disease: mechanisms and clinical relevance","volume":"147","author":"Luedde","year":"2014","journal-title":"Gastroenterology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216621","article-title":"Icaritin with autophagy\/mitophagy inhibitors synergistically enhances anticancer efficacy and apoptotic effects through PINK1\/Parkin-mediated mitophagy in hepatocellular carcinoma","volume":"587","author":"Luo","year":"2024","journal-title":"Cancer Lett."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.16136","article-title":"Evaluating the antifibrotic potential of naringenin, asiatic acid, and icariin using murine and human precision-cut liver slices","volume":"12","author":"Luo","year":"2024","journal-title":"Physiol. Rep."},{"key":"B3","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jep.2011.01.001","article-title":"The genus Epimedium: an ethnopharmacological and phytochemical review","volume":"134","author":"Ma","year":"2011","journal-title":"J. Ethnopharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.1016\/j.apsb.2024.06.029","article-title":"Icaritin inhibits the progression of urothelial cancer by suppressing PADI2-mediated neutrophil infiltration and neutrophil extracellular trap formation","volume":"14","author":"Mou","year":"2024","journal-title":"Acta Pharm. Sin. B."},{"key":"B11","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1111\/cas.14641","article-title":"Icaritin-induced immunomodulatory efficacy in advanced hepatitis B virus-related hepatocellular carcinoma: immunodynamic biomarkers and overall survival","volume":"111","author":"Qin","year":"2020","journal-title":"Cancer Sci."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112296","article-title":"Direct targeting of S100A9 with Icariin counteracted acetaminophen-induced hepatotoxicity","volume":"136","author":"Shen","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112533","article-title":"Icaritin attenuates ischemia-reperfusion injury by anti-inflammation, anti-oxidative stress, and anti-autophagy in mouse liver","volume":"138","author":"Sun","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23147519","article-title":"Bioavailability improvement strategies for Icariin and its derivates: a review","volume":"23","author":"Szab\u00f3","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2147\/cmar.s414487","article-title":"The synergy of gene targeting drug Icaritin soft capsule with immunomodulator and TACE brings new hope for drug combination in patients with advanced liver cancer: a case report and literature review","volume":"15","author":"Tang","year":"2023","journal-title":"Cancer Manage. Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.5948","article-title":"Integrating metabolomics and bioinformatics to reveal the mechanism of Epimedium-induced liver injury","volume":"38","author":"Wang","year":"2024","journal-title":"Biomed. Chromatograph: BMC"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/molecules21091158","article-title":"Icariin metabolism by human intestinal microflora","volume":"21","author":"Wu","year":"2016","journal-title":"Molecules"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/foods11060882","article-title":"Comparison of flavonoid O-glycoside, C-glycoside and their aglycones on antioxidant capacity and metabolism during in vitro digestion and in vivo","volume":"11","author":"Xie","year":"2022","journal-title":"Foods (Basel Switzerland)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"31927","DOI":"10.1093\/annonc\/mdv523.86","article-title":"A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and Malignant growth through the IL-6\/Jak2\/Stat3 pathway","volume":"6","author":"Zhao","year":"2015","journal-title":"Oncotarget"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3745051","article-title":"The toxicity and metabolism properties of Herba Epimedii flavonoids on laval and adult zebrafish","volume":"2019","author":"Zhong","year":"2019","journal-title":"Evid Based Complement Alternat Med."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2024.110926","article-title":"Icaritin activates p53 and inhibits aerobic glycolysis in liver cancer cells","volume":"392","author":"Zhou","year":"2024","journal-title":"Chem. Biol. Interact."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1799319\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:51:12Z","timestamp":1776837072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1799319\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":31,"alternative-id":["10.3389\/fcimb.2026.1799319"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1799319","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"article-number":"1799319"}}